Startup India Government of India
Innule Biosciences Private Limited
Innule Biosciences Private Limited - chemicals in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹12.5 Lakh
▼ 17% YoY
Net loss · FY 2024
₹40,840
Net margin -3.3%
EBITDA · FY 2024
-₹42,520
EBITDA margin -3.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹52,630
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Innule Biosciences Private Limited
Data last updated:
Innule Biosciences Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 15 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2020PTC131629. Its GSTIN is 29AAFCI5472C1ZJ (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹52,630. It is led by directors Koteppa Pari and Pari Veerappa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore Bioinnovation Centre Helix Biotech Park Electronic City Phase – 1, Karnataka, India – 560100.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.5 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹40,840 (net margin -3.3%) and EBITDA of -₹42,520 (EBITDA margin -3.4%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
The company is associated with 1 brand: Innule Biosciences.
Innule Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0151292).
Company Details of Innule Biosciences Private Limited
CIN U24231KA2020PTC131629
Registration Number 131629
Incorporation Date 15 January 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0151292
Key People
Koteppa Pari Director Pari Veerappa Director Recognitions & Rankings of Innule Biosciences
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0151292
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBangalore Bioinnovation Centre Helix Biotech Park Electronic City Phase – 1, Karnataka, India – 560100
- IndustryChemicals, Manufacturing, Pharmaceutical Chemical, Other Chemical Product
Comprehensive company report
Innule Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Innule Biosciences Private Limited
Innule Biosciences operates one associated brand: Innule Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Recombinant proteins, custom proteins, and insulin products are produced. | innulebio.in |
Financials of Innule Biosciences Private Limited FY 2025 filings available
Innule Biosciences Private Limited reported revenue of ₹12.5 Lakh (down 17% YoY) for FY 2024.
Revenue · FY 2024
₹12.5 Lakh ▼ 17%
Net loss · FY 2024
₹40,840 margin -3.3%
EBITDA · FY 2024
-₹42,520 margin -3.4%
Compounded Annual Growth Rate (CAGR) of Innule Biosciences Private Limited
Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▲ 97%
3 years · compounded
▲ 55%
Revenue has declined at a compounded annual rate (CAGR) of 6% over three years, including a 17% fall in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Innule Biosciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹42,520 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹40,840 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Innule Biosciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Innule Biosciences are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Innule Biosciences Private Limited
Innule Biosciences has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Koteppa Pari | Director | 15 Jan 2020 | 6 Years 9 Months | Current |
| Pari Veerappa | Director | 15 Jan 2020 | 6 Years 9 Months | Current |
Peer Comparison of Innule Biosciences Private Limited
Innule Biosciences Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biosciences). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cology Biosciences Private Limited | ₹13.81 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Biorex Biosciences Private Limited | ₹13.6 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Azyme Biosciences Private Limited | ₹13.53 Lakh (FY 2024) | •••• | •••• | 22.0% | •••• | Bangalore, Karnataka, India |
| Biopol Biosciences Private Limited | ₹13.09 Lakh (FY 2025) | •••• | •••• | -56.0% | •••• | Bangalore, Karnataka, India |
| Vedic Biosciences Private Limited | ₹13.02 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Bhubaneswar, Odisha, India |
| Innule Biosciences Private Limited this company | ₹12.5 Lakh (FY 2024) | •••• | •••• | -17.0% | •••• | Bangalore, Karnataka, India |
| Nakshi Biosciences Private Limited | ₹12.5 Lakh (FY 2025) | •••• | •••• | 48.0% | •••• | Ahmedabad, Gujarat, India |
| Globalstar Biosciences Private Limited | ₹12.39 Lakh (FY 2024) | •••• | •••• | 61.0% | •••• | Kolhapur, Maharashtra, India |
| Mothercell Biosciences Private Limited | ₹12 Lakh (FY 2025) | •••• | •••• | -75.0% | •••• | Hyderabad, Telangana, India |
| Speranta Biosciences Private Limited | ₹11.92 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Allahabad, Uttar Pradesh, India |
| Azaleos Biosciences Private Limited | ₹11 Lakh (FY 2024) | •••• | •••• | 33.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Innule Biosciences by revenue in the Biotechnology industry (Biosciences), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Innule Biosciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Innule Biosciences Private Limited
Innule Biosciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Innule Biosciences Private Limited
Employment history and EPFO contributions of people linked to Innule Biosciences.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Innule Biosciences Private Limited
Innule Biosciences Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Koteppa Pari was appointed as Director on 15 Jan 2020.
AGM
Innule Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Innule Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Koteppa Pari was appointed as Director.
Appointed
Pari Veerappa was appointed as Director.
Incorporation
15 Jan 2020
Innule Biosciences Private Limited was registered on 15 Jan 2020 with Roc Bangalore & aged 6 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Innule Biosciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Innule Biosciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Innule Biosciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Innule Biosciences Private Limited
Innule Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCI5472C1ZJ | Karnataka | Active | 11 Jun 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Innule Biosciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innule Biosciences Private Limited
Innule Biosciences is an active private limited company based in Bangalore, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 15 January 2020 (6+ years old) and is registered under CIN U24231KA2020PTC131629.
Innule Biosciences reported revenue of ₹12.5 Lakh for FY 2024 (down 17% YoY).
Innule Biosciences has 2 current directors:
- Koteppa Pari - Director
- Pari Veerappa - Director
Innule Biosciences reported a net loss of ₹40,840 (net margin -3.3%) and EBITDA of -₹42,520 (EBITDA margin -3.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Innule Biosciences is -6% over three years. In the latest year (FY 2024) revenue fell 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Innule Biosciences is 29AAFCI5472C1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Innule Biosciences is U24231KA2020PTC131629. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innule Biosciences was incorporated on 15 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Innule Biosciences by revenue are Cology Biosciences Private Limited, Biorex Biosciences Private Limited, Azyme Biosciences Private Limited, Biopol Biosciences Private Limited, Vedic Biosciences Private Limited and 5 more, all in the Biotechnology industry (Biosciences).
Koteppa Pari was appointed as Director on 15 Jan 2020. Pari Veerappa was appointed as Director on 15 Jan 2020.
Yes, Innule Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).